Newstral
Article
jdsupra.com on 2019-09-28 18:05
FDA issues draft guidance on providing regulatory submissions in electronic format
Related news
New USPTO Requirement: Mandatory Electronic Trademark Submissions and Physical Addressesjdsupra.com
Electronic Voluntary Correction Program Submissions Required After March 31, 2019jdsupra.com
Pilot program for 510(k) electronic submissions is requesting participantsjdsupra.com
FDA Year in Review: A Shifting Regulatory Landscapejdsupra.com
FDA Regulatory Check-Up: CBD and Dietary Supplementsjdsupra.com
[Audio] Podcast: Non-binding Guidance: Real-World Evidence in Drug Development and FDA Submissionsjdsupra.com
OSHA Injury and Illness Records: Next Round of Electronic Submissions Due July 1jdsupra.com
FDA Reduces Regulatory Burden for Certain Medical Image Analyzersjdsupra.com
The FDA Regulatory Landscape for Covid-19 Treatments and Vaccinesjdsupra.com
FDA Launches eSTAR Pilot Program to Further Simplify Medical Device 510(k) Submissionsjdsupra.com
Aiming to Foster Innovation, FDA Proposes Regulatory Framework Specific to Prescription Drug Softwarejdsupra.com
Consumer Product Regulatory Priorities in 2019: An Ever-Shifting Landscape for FDAjdsupra.com
FDA Guidance Expands Regulatory Requirements For Face Masks And Respiratorsjdsupra.com
President Signs Bipartisan Law Revising Dodd-Frank and Providing Regulatory Relief to U.S. Financial Institutionsjdsupra.com
Proposed changes to FDA guidance for the content of premarket submissions for management of cybersecurity in medical devices: What you should knowjdsupra.com
Navigating the U.S. FDA regulatory clearance for digital medical devices: the 510(k) and Pre-Cert programjdsupra.com
Who Me? Yes, You. Couldn’t Be. Then Who?: FDA Reinforces That Contract Manufacturers Can’t Delegate Away Regulatory Responsibilitiesjdsupra.com
FDA Strives to Adapt Regulatory Approach to Rapidly Evolving Digital Health Spacejdsupra.com
FDA launches temporary “TRIP” program to help HCT/P sponsors gain regulatory clarityjdsupra.com
When Juul won ‘nicotine arms race,’ did it ace out FDA regulatory threats, too?jdsupra.com